Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 263

1.
2.

Are women worldwide under-treated with regard to cardiac resynchronization and sudden death prevention?

Curtis AB.

J Interv Card Electrophysiol. 2006 Dec;17(3):169-75. Review.

PMID:
17333368
3.

Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial.

Saxon LA, Bristow MR, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, Feldman AM, Galle E, Ecklund F.

Circulation. 2006 Dec 19;114(25):2766-72.

4.

Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.

Ghanbari H, Dalloul G, Hasan R, Daccarett M, Saba S, David S, Machado C.

Arch Intern Med. 2009 Sep 14;169(16):1500-6. doi: 10.1001/archinternmed.2009.255.

PMID:
19752408
5.

The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator.

Yao G, Freemantle N, Calvert MJ, Bryan S, Daubert JC, Cleland JG.

Eur Heart J. 2007 Jan;28(1):42-51.

PMID:
17110403
6.

Cardiac defibrillation and resynchronization therapies: principles, therapies, and management implications.

Bubien RS, Ching EA, Kay GN.

AACN Clin Issues. 2004 Jul-Sep;15(3):340-61. Review.

PMID:
15475810
7.

Update of implantable cardioverter/defibrillator and cardiac resynchronization therapy in heart failure.

Rami T, Shih HT.

Curr Opin Cardiol. 2004 May;19(3):264-9. Review.

PMID:
15096960
8.

Current role of device therapy to reduce sudden cardiac death in heart failure.

Kang S, Cannom DS.

Curr Heart Fail Rep. 2004 Sep;1(3):104-10. Review.

PMID:
16036033
9.

Is implantable defibrillator indicated in all patients on cardiac resynchronization therapy?

Pieragnoli P, Ricciardi G, Colella A, Musilli N, Porciani MC, Giaccardi M, Padeletti L, Michelucci A.

Minerva Cardioangiol. 2006 Dec;54(6):735-41. Review.

PMID:
17167385
10.
11.

Outcomes of elderly heart failure recipients of ICD and CRT.

Grimm W.

Int J Cardiol. 2008 Apr 10;125(2):154-60. Review.

PMID:
17976843
12.

The future of implantable defibrillator and cardiac resynchronization therapy trials.

Saksena S, Nagarakanti R.

J Interv Card Electrophysiol. 2008 Oct;23(1):29-39. doi: 10.1007/s10840-008-9302-6. Review.

PMID:
18758929
13.

[Cardiac resynchronization therapy-always with ICD?].

Stellbrink C.

Herz. 2005 Nov;30(7):596-600. German.

PMID:
16333584
14.
15.

Benefit of combined resynchronization and defibrillator therapy in heart failure patients with and without ventricular arrhythmias.

Ypenburg C, van Erven L, Bleeker GB, Bax JJ, Bootsma M, Wijffels MC, van der Wall EE, Schalij MJ.

J Am Coll Cardiol. 2006 Aug 1;48(3):464-70.

16.

Cardiac resynchronization therapy: which device to implant?

Leclercq C, Mabo C, Daubert JC.

Arch Cardiovasc Dis. 2008 Jan;101(1):55-60. Review.

17.

[Cardiac resynchronization therapy and prevention of sudden cardiac death in heart failure. From clinical trials to clinical practice].

Silva Melchor L, García-Pavía P, Ortigosa Aso J.

Rev Esp Cardiol. 2006 Jul;6 Suppl F:59-70. Review. Spanish.

18.

Cardiac resynchronization therapy in combination with implantable cardioverter-defibrillator.

Daubert JC, Leclercq C, Mabo P.

Europace. 2009 Nov;11 Suppl 5:v87-92. doi: 10.1093/europace/eup305. Review.

PMID:
19861397
19.
20.

Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial.

Russo AM, Poole JE, Mark DB, Anderson J, Hellkamp AS, Lee KL, Johnson GW, Domanski M, Bardy GH.

J Cardiovasc Electrophysiol. 2008 Jul;19(7):720-4. doi: 10.1111/j.1540-8167.2008.01129.x.

PMID:
18373605

Supplemental Content

Support Center